| Gene symbol | TNFRSF17 | Synonyms | BCM, BCMA, CD269, TNFRSF13A | Type of gene | protein-coding |
| Chromosome | 16 | Map location | 16p13.13 | dbXrefs | |
| Description | TNF receptor superfamily member 17 | ||||
| Gene symbol | SDC1 | Synonyms | CD138, SDC, SYND1, syndecan | Type of gene | protein-coding |
| Chromosome | 2 | Map location | 2p24.1 | dbXrefs | |
| Gene perturbation-related omics dataset | PerturbAtlas | ||||
| Description | syndecan 1 | ||||
| GTO ID | GTC0803 |
| Trial ID | ChiCTR1900023624 |
| Disease | Multiple Myeloma |
| Altered gene | BCMA|CD138 |
| Therapeutic/Target gene | Target gene |
| Therapy | CAR-T cell |
| Treatment | BCMA/CD138 CAR-T cells |
| Phase | Phase2 |
| Recruitment status | Not Recruiting |
| Title | BCMA-CAR-T\CD138-CAR-T cell sequential therapy for relapse refractory Multiple Myeloma clinical study |
| Year | 2019 |
| Country | China |
| Company sponsor | He'nan Provincial People's Hospital |
| Cohort 1 | |||||||
|
|||||||